2023 annual financial data
aTyr Pharma 2023 Operating margin
Direct answer
Operating margin was -15,557.79%.
Operating income was -54,919,000 USD and net income was -50,389,000 USD.
Operating cash flow was -33,221,000 USD.
Get free aTyr Pharma email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 353,000 USD
- Operating income
- -54,919,000 USD
- Net income
- -50,389,000 USD
- Operating cash flow
- -33,221,000 USD